Key facts
| Price (PPV) | 449 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | bicalutamide |
| Class | Endocrine therapy |
| ATC code | L02BB03 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 299 MAD |
| Data collected on | 9/8/2026 |
Indications
Cancer de la prostate métastasé Cancer de la prostate métastasé, en association à une castration médicale ou chirurgicale. Cancer de la prostate localement avancé Bicalutamide est indiqué chez les patients atteints d’un cancer de la prostate localement avancé, à haut risque de progression de la maladie, soit en traitement seul soit en traitement adjuvant à la prostatectomie radicale ou à la radiothérapie.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 5 other products contain the same active substance as Protadex 50 mg (Bicalutamide), at the same strength and in the same dosage form. For the same pack size (Boite de 28), the cheapest is Bicalutamide Pharmed 50 mg (PHARMED) at 434 MAD, i.e. 3 % less than Protadex 50 mg (449 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Bicalutamide Pharmed 50 mg | PHARMED | Boite de 28 | 434 MAD | 15.50 / unit | −3 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Bicalutamide Zenith 50 mg | ZENITH PHARMA | Boite 10 | 197.10 MAD | — |
| Bicalutamide GT 50 mg | ATLAS PHARM | Boîte de 30 | 478 MAD | 15.93 / unit |
| Bicalutamide Zenith 50 mg | ZENITH PHARMA | Boite de 30 | 478 MAD | 15.93 / unit |
| Bicalutamide GT 50 mg | ATLAS PHARM | Boîte de 60 | 903 MAD | 15.05 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Protadex 50 mg
Protadex 50 mg belongs to the endocrine therapy therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Protadex 50 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Protadex 50 mg
Answers to common questions from Moroccan patients about this drug.